Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | LIF | 116.0 | 59 | |
| N2586 | JNK-IN-11 | 0.3 | uM | 1 | LIF | 120.0 | 68 | ||||
| RA2159 | IGF-I | 100 | ug/mL | 1 | LIF | 114.5 | 58 | ||||
| RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 114.0 | 56 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 169.0 | 53 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 125.5 | 40 | |
| RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 112.0 | 45 | |
| RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 118.0 | 60 | |
| RA2159 | 1 | LIF | 82.5 | 68 | |||||||
| N2586 | IGF-I | 100 | ug/mL | 1 | LIF | 167.0 | 57 | ||||
| N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 129.5 | 72 | |
| N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 122.5 | 48 | |
| N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 140.0 | 49 | |
| N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 133.0 | 36 | |
| N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | LIF | 166.0 | 41 | |
| N2586 | 1 | LIF | 118.0 | 41 | |||||||
| RA2159 | Adiponectin | 5 | ng/mL | 1 | LIF | 115.0 | 56 | ||||
| RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | LIF | 109.0 | 59 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | LIF | 116.0 | 49 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | LIF | 116.0 | 57 | |
| RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | LIF | 150.0 | 62 | |
| RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | LIF | 143.0 | 51 | |
| N2586 | Adiponectin | 5 | ng/mL | 1 | LIF | 171.0 | 67 | ||||
| N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | LIF | 151.0 | 60 | |
| N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | LIF | 140.5 | 46 |